Is Oscar Health (OSCR) The High Growth Low Debt Stock to Invest in Now?
March 22, 2025
We recently published a list of 12 High Growth Low Debt Stocks to Invest in Now. In this article, we are going to take a look at where Oscar Health, Inc. (NYSE:OSCR) stands against other high growth low debt stocks to invest in now.
The global financial markets are experiencing heightened volatility, influenced by a confluence of economic and geopolitical factors. The broader market has entered correction territory, reflecting investor apprehension regarding escalating trade tensions and potential economic slowdowns.
The recent imposition of tariffs by the United States has been a significant catalyst for market fluctuations. In response, major indices such as the broader market and Nasdaq Composite have experienced notable declines. This environment has led to a reassessment of investment strategies, with a growing emphasis on asset quality and financial resilience.
While debt can be a useful tool for fueling growth, excessive debt levels can pose significant risks. High debt-to-equity (D/E) ratios indicate that a company is heavily reliant on borrowed funds, which can lead to financial strain, especially during economic downturns. Companies with D/E ratios exceeding 2.0 are generally considered risky, as they may face challenges in meeting their debt obligations, potentially leading to insolvency.
Conversely, companies with low debt levels enjoy several advantages. They have greater financial stability, as they are less burdened by interest payments and have a reduced risk of bankruptcy. This financial flexibility allows them to invest more in growth opportunities, such as research and development, marketing, or capital expenditures, without the constraints of significant debt obligations. Moreover, these companies are often more attractive to investors, as they present a lower risk profile.
In the current climate, focusing on high-growth companies with low debt levels can be a prudent strategy. These companies typically exhibit robust earnings growth and the ability to navigate economic headwinds effectively. Financial advisors are also increasingly recommending investments in quality stocks characterized by strong earnings, low debt, and reliable management. This approach focuses on identifying firms that are expanding without overleveraging, thereby maintaining financial stability and operational flexibility.
High-growth companies are characterized by their ability to increase revenues and earnings at a rate significantly above the market average. This rapid expansion often leads to substantial capital appreciation for investors. For instance, companies with low debt have historically outperformed their high-debt counterparts. Over a 23-year period, low-debt growth companies achieved annualized returns of 17.1%, compared to just 7.5% for high-debt firms. Notably, low-debt stocks outperformed high-debt stocks in 19 of those 23 years, equating to an 83% beat rate. Given this, we will take a look at some of the best high growth stocks with low debt.
To identify high-growth, low-debt stocks, we screened for companies with strong competitive advantages and an estimated average annual EPS growth rate of over 15% for the next five years, based on data from FINVIZ.com. Additionally, we filtered for companies with a debt-to-equity ratio below 0.5. The EPS Next 5 Year growth rate was used as the primary ranking metric. The final list of stocks is ranked in ascending order of EPS growth rate, prioritizing companies with the strongest earnings expansion potential.
At Insider Monkey, we are obsessed with hedge funds. Why are we interested in the stocks that hedge funds pile into? The reason is simple: our research has shown that we can outperform the market by imitating the top stock picks of the best hedge funds. Our quarterly newsletter’s strategy selects 14 small-cap and large-cap stocks every quarter and has returned 373.4% since May 2014, beating its benchmark by 218 percentage points (see more details here).
A close up of a patient and a healthcare professional engaging in conversation, showing the company’s commitment to patient care.
EPS Growth Rate (Next 5 Years): 161.23%
Oscar Health, Inc. (NYSE:OSCR) is a technology-driven health insurance company that provides individual, family and small group plans through its proprietary +Oscar platform.
On 18 Nov 2024, Oscar Health, Inc. (NYSE:OSCR) announced that CEO Mark Bertolini’s Anahata Foundation purchased 933,333 shares in the open market, signaling strong insider confidence in the company’s future. Bertolini emphasized his belief in Oscar’s technology, talent, and products to revolutionize healthcare, reinforcing the company’s growth potential and long-term strategy. The purchase highlights executive commitment to Oscar’s mission of expanding its footprint in the individual insurance market.
Oscar Health, Inc. (NYSE:OSCR) delivered a record FY2024, achieving its first-ever net income and Adjusted EBITDA profitability. Revenue surged 56.5% YoY to $9.2 billion, driven by strong membership growth. The company reported a net income of $25.4 million a $296.2 million YoY improvement, and an Adjusted EBITDA of $199.2 million, up $244.5 million YoY. Looking ahead, Oscar expects FY2025 revenue of $11.2-$11.3 billion and Earnings from Operations of $225-$275 million, signaling continued profitability and disciplined cost management.
Overall, OSCR ranks 3rd on our list of high growth low debt stocks to invest in now. While we acknowledge the potential for OSCR as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and doing so within a shorter time frame. If you are looking for an AI stock that is more promising than OSCR but that trades at less than 5 times its earnings, check out our report about the cheapest AI stock.
READ NEXT: 20 Best AI Stocks To Buy Now and 30 Best Stocks to Buy Now According to Billionaires
Disclosure: None. This article is originally published at Insider Monkey.
Terms and Privacy Policy
Search
RECENT PRESS RELEASES
Related Post